Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónWO2012170677 A1
Tipo de publicaciónSolicitud
Número de solicitudPCT/US2012/041333
Fecha de publicación13 Dic 2012
Fecha de presentación7 Jun 2012
Fecha de prioridad7 Jun 2011
También publicado comoCA2838529A1, CN103732213A, EP2717855A1, EP2717855A4, US8778383, US20130074842, US20150101597
Número de publicaciónPCT/2012/41333, PCT/US/12/041333, PCT/US/12/41333, PCT/US/2012/041333, PCT/US/2012/41333, PCT/US12/041333, PCT/US12/41333, PCT/US12041333, PCT/US1241333, PCT/US2012/041333, PCT/US2012/41333, PCT/US2012041333, PCT/US201241333, WO 2012/170677 A1, WO 2012170677 A1, WO 2012170677A1, WO-A1-2012170677, WO2012/170677A1, WO2012170677 A1, WO2012170677A1
InventoresRichard Boucher, Michael Ross Johnson, William R. Thelin, Brian Button, Tomas Navratil
SolicitanteParion Sciences, Inc.
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos:  Patentscope, Espacenet
Methods of treatment
WO 2012170677 A1
Descripción  disponible en inglés
Reclamaciones  disponible en inglés
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US5489538 Abr 189529 Oct 1895 Harness-tug
US42684605 Mar 198019 May 1981Warner-Lambert CompanyNebulizer
US447993218 May 198230 Oct 1984University Of FloridaBrain-specific drug delivery
US454056422 Jul 198310 Sep 1985University Of FloridaBrain-specific drug delivery
US529249819 Jun 19918 Mar 1994The University Of North Carolina At Chapel HillMethod of treating lung disease with uridine triphosphates
US565625614 Dic 199412 Ago 1997The University Of North Carolina At Chapel HillMethods of treating lung disease by an aerosol containing benzamil or phenamil
US5817028 *23 Feb 19956 Oct 1998Central Sydney Area Health ServiceMethod and device for the provocation of air passage narrowing and/or the induction of sputum
US622374515 Oct 19971 May 2001Aga AktiebolagMethod and a device for producing a fine homogeneous aerosol
US626497520 Oct 199924 Jul 2001The University Of North Carolina At Chapel HillMethods of hydrating mucosal surfaces
US63485896 Feb 199819 Feb 2002Inspire Pharmaceuticals, Inc.Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
US681862925 Mar 200316 Nov 2004Inspire Pharmaceuticals, Inc.Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US69772466 Nov 200120 Dic 2005Inspire Pharmaceuticals, Inc.Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
US72237447 Oct 200429 May 2007Inspire Pharmaceuticals, Inc.Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US753152523 Mar 200712 May 2009Inspire Pharmaceuticals, Inc.P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis
US20030091512 *3 Sep 200215 May 2003Akwete AdjeiWater stabilized medicinal aerosol formulation
US20080090841 *7 Sep 200717 Abr 2008Parion Sciences, Inc.Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
US20080199410 *19 Sep 200721 Ago 2008Discovery Laboratories, Inc.Pulmonary surfactant formulations and methods for promoting mucus clearance
US20090104272 *10 Oct 200823 Abr 2009Parion Sciences, Inc.Inhaled hypertonic saline delivered by a heated nasal cannula
US200903060096 Dic 200610 Dic 2009P2-Science ApsModulation of the P2Y2 Receptor Pathway
US201002581145 Feb 201014 Oct 2010Vapotherm, Inc.Heated nebulizer devices, nebulizer systems, and methods for inhalation therapy
Otras citas
Referencia
1"Remington: The Science and Practice of Pharmacy", vol. II, 1995, pages: 1457
2BODOR, N. ET AL., J. MED. CHEM., vol. 26, 1983, pages 313 - 318
3BODOR, N. ET AL., J. PHARM. SCI., vol. 67, 1978, pages 1045 - 1050
4BODOR, N. ET AL., J. PHARM. SCI., vol. 75, 1986, pages 29 - 35
5DE BOECK ET AL., EUR RESPIR J, vol. 37, no. 5, 2011, pages 1091 - 5
6ELKINS ET AL., N ENGL J MED, vol. 354, no. 3, 2006, pages 229 - 40
7FLUME ET AL., AM J RESPIR CRIT CARE MED., vol. 176, no. 10, 15 November 2007 (2007-11-15), pages 957 - 69
8J. S. HANDLER ET AL., COMP. BIOCHEM. PHYSIOL, vol. 117, 1997, pages 301 - 306
9M. BURG, AM. J. PHYSIOL., vol. 268, 1995, pages F983 - F996
10RAMSEY ET AL., N ENGL J MED, vol. 340, no. 1, 1999, pages 23 - 30
11 *RANDELL ET AL.: "Effective Mucus Clearance Is Essential for Respiratory Health", AMERICAN JOUMAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, vol. 35, no. 1, 9 March 2006 (2006-03-09), pages 20 - 28, XP055137566
12REN ET AL., J PEDIATR., vol. 153, no. 6, 2008, pages 746 - 51
13 *See also references of EP2717855A4
14SHEK, E. ET AL., J. MED. CHEM., vol. 19, 1976, pages 113 - 117
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
EP2978434A4 *30 May 201317 Ago 2016Pharmacaribe LlcCompositions, formulations and methods of bio-balancing the ph of sterile isotonic saline and hypertonic saline solutions
EP3043650A4 *10 Sep 20138 Nov 2017Kenneth P GlynnCarbon dioxide and saline nasal delivery methods and delivery devices
Eventos legales
FechaCódigoEventoDescripción
6 Feb 2013121Ep: the epo has been informed by wipo that ep was designated in this application
Ref document number: 12797275
Country of ref document: EP
Kind code of ref document: A1
5 Dic 2013ENPEntry into the national phase in:
Ref document number: 2838529
Country of ref document: CA
6 Dic 2013ENPEntry into the national phase in:
Ref document number: 2014514631
Country of ref document: JP
Kind code of ref document: A
9 Dic 2013NENPNon-entry into the national phase in:
Ref country code: DE
23 Ene 2014ENPEntry into the national phase in:
Ref document number: 2012267938
Country of ref document: AU
Date of ref document: 20120607
Kind code of ref document: A